Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and sitagliptin in impaired glucose tolerance after recent TIA or minor ischemic stroke
2011-005980-26Phase 2Active
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in prediabetes comparing Metformin with Sitagliptin (2 arms). Primary endpoint: Effectiveness, feasibility and safety comparison. Started Feb 2012; status: active.
02
Drugs
metforminsitagliptin
03
Conditions
prediabetes
Beyond the preview
Go deeper on 2011-005980-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005980-26.